Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Global - API Market (Billion US$), 2014-2020
Figure 5-1: Worldwide Population above 60 Years (Billion), 2014 & 2050
Figure 5-2: US - Population Suffering from Chronic Condition (Million), 2014 & 2020
Figure 6-1: Global - Share of Captive and Merchant Market in API Market (2014)
Figure 6-2: Global - API Captive Market (Billion US$), 2014-2020
Figure 6-3: Global - API Merchant Market (Billion US$), 2014-2020
Figure 6-4: Global - Share of Branded and Generic Market in API Market (2014)
Figure 6-5: Global - Generic API Market (Billion US$), 2014-2020
Figure 6-6: Global - Branded API Market (Billion US$), 2014-2020
Figure 6-7: Global - Share of Synthetic and Biotech APIs in API Market (2014)
Figure 6-8: Global - Chemical/Small Molecule API Market (Billion US$), 2014-2020
Figure 6-9: Global - Biotech API Market (Billion US$), 2014-2020
Figure 6-10: North America - API Market (Billion US$), 2014-2020
Figure 6-11: Asia-Pacific - API Market (US$ Billion), 2014-2020
Figure 6-12: Europe - API Market (Billion US$), 2014-2020
Figure 6-13: ROW - API Market (Billion US$), 2014-2020
Figure 6-14: Breakup of Global API Market by Therapeutic Segments (%), 2014
Figure 8-1: BASF SE - Break up of Revenue by Geographic Segment (%), 2014
Figure 8-2: Kyowa Hakko Kirin - Break up of Revenue by Geographic Segment (%), 2014
Figure 8-3: Teva Pharmaceutical Industries Limited - Break up of Revenue by Geographical Segment (%), 2014
Figure 8-4: Lonza - Break up of Revenue by Geographic Segment (%), 2014
Figure 8-5: Dr. Reddy's Laboratories - Break up of Revenue by Geographic Segment (%), 2014
Figure 8-6: Aurobindo Pharma Limited - Break up of Revenue by Geographic Segment (%), 2014
Figure 8-7: Pfizer - Break up of Revenue by Geographic Segment (%), 2014
Figure 8-8: Divis Laboratories Limited - Break up of Revenue by Geographic Segment (%), 2014
Figure 8-9: Royal DSM - Break up of Revenue by Geographic Origin (%), 2014
Figure 8-10: Boehringer Ingelheim GmbH - Break up of Revenue by Geographic Segment (%), 2014

List of Tables:

Table 3-1: Classification of Bulk Drugs
Table 5-1: Blockbuster Drugs Going Off Patent (2014-2015)
Table 8-1: BASF SE - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-2: Kyowa Hakko Kirin - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-3: Teva Pharmaceutical Industries Limited - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-4: Lonza - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-5: Dr. Reddy's Laboratories - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-6: Aurobindo Pharma Limited - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-7: Pfizer - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-8: Divis Laboratories Limited - Revenues (Billion US$), 2013 & 2014
Table 8-9: Royal DSM - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 8-10: Boehringer Ingelheim GmbH - Revenues by Business Segment (Billion US$), 2013 & 2014